2016
Corticosteroids Versus Pentoxifylline for Severe Alcoholic Hepatitis
Njei B, Do A, McCarty TR, Fortune BE. Corticosteroids Versus Pentoxifylline for Severe Alcoholic Hepatitis. Journal Of Clinical Gastroenterology 2016, 50: 871-881. PMID: 27404293, PMCID: PMC5065367, DOI: 10.1097/mcg.0000000000000585.Peer-Reviewed Original ResearchConceptsSevere alcoholic hepatitisAlcoholic hepatitisTrial sequential analysisShort-term mortalityHepatorenal syndromeStudies satisfied inclusion criteriaEffect of corticosteroidsSatisfied inclusion criteriaMortality benefitSignificant morbidityCochrane CollaborationEpidemiologic evidenceCochrane LibraryInclusion criteriaCorticosteroidsHepatitisIndependent reviewersTherapeutic strategiesThird investigatorPentoxifyllinePublication statusPlaceboComprehensive searchMortalityInitial reviewers
2015
Factors Affecting the Efficacy of Nonsteroidal Anti-inflammatory Drugs in Preventing Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis
Rustagi T, Njei B. Factors Affecting the Efficacy of Nonsteroidal Anti-inflammatory Drugs in Preventing Post–Endoscopic Retrograde Cholangiopancreatography Pancreatitis. Pancreas 2015, 44: 859-867. PMID: 26168316, PMCID: PMC4824288, DOI: 10.1097/mpa.0000000000000326.Peer-Reviewed Original ResearchConceptsPost-endoscopic retrograde cholangiopancreatography pancreatitisNonsteroidal anti-inflammatory drugsAnti-inflammatory drugsCholangiopancreatography pancreatitisRectal administrationIncidence of PEPRisk of PEPPreventing Post-Endoscopic Retrograde Cholangiopancreatography PancreatitisPancreatic duct injectionOddi dysfunctionSubgroup analysisDuct injectionPatientsTreatment typeRelevant studiesERCPPancreatitisSignificant reductionAdministrationDrugsEfficacySignificant benefitsRiskPlaceboSphincter